How to prescribe antihistamines for chronic idiopathic urticaria: Desloratadine daily vs PRN and quality of life

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 4, 2009, Pages 605-612

  Grob, J J ^a   Auquier, P ^b   Dreyfus, I ^c   Ortonne, J P ^d  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b Service de Santé Publique   (France)

^c Schering Plough   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Chronic urticaria; Desloratadine; Quality of life

Indexed keywords

DESLORATADINE; PLACEBO;

ADULT; ALERTNESS; ARTICLE; CHRONIC URTICARIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALAISE; MALE; MOOD; MULTICENTER STUDY; NAUSEA; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SOCIAL INTERACTION; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; QUALITY OF LIFE; URTICARIA;

EID: 62449095217     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01913.x     Document Type: Article

References (25)

1. Greaves MW. Chronic urticaria. N Engl J Med 1995 332 : 1767 1772.
2. 2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006 61 : 316 320.
3. Sabroe RA, Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol 1997 133 : 1003 1008.
4. Berger WE. The safety and efficacy of desloratadine for the management of allergic disease. Drug Saf 2005 28 : 1101 1118.
5. Weldon DR. Quality of life in patients with urticaria. Allergy Asthma Proc 2006 27 : 96 99.
6. Grob JJ, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol 2006 30 : 47 51.
7. 2oL). Allergy 2005 60 : 1073 1078.
8. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997 136 : 197 201.
9. Patrick DL. Assessing health-related quality of life outcomes. In : Heithoff KA, Lohr KN, editors. Effectiveness and outcomes in health care: proceedings of an invitational conference by the Institute of Medicine. Washington, DC : National Academies Press, 1990 : 137 151.
10. 2LEN/EDF guideline: management of urticaria. Allergy 2006 61 : 321 331.
11. Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003 58 : 621 623.
12. Grob JJ, Auquier P, Martin S, Lancon C, Bonerandi JJ, the Réseau d'Epidémiologie en Dermatologie. Development and validation of a quality of life measurement for chronic skin disorders in French: VQ-Dermato. Dermatology 1999 199 : 213 222.
13. Société Française de Dermatologie. Consensus conference: management of chronic urticaria. Wednesday 8 January 2003. Institut Pasteur-Paris, France. Recommendations (short version). Eur J Dermatol 2003 13 : 385 392.
14. Ring J, Hein R, Gauger A, Bronsky E, Miller B, the Desloratadine Study Group. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. Int J Dermatol 2001 40 : 726.
15. Monroe E, Finn A, Patel P, Guerrero R, Ratner P, Bernstein D et al. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomised, placebo-controlled trial. J Am Acad Dermatol 2003 48 : 535 541.
16. Ortonne J-P, Grob J-J, Auquier P, Dreyfus I. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol 2007 8 : 37 42.
17. Grob JJ, Auquier P, Dreyfus I, Ortone JP. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomised, double-blind, multicenter, placebo-controlled study. J Eur Acad Dermatol Venereol 2008 22 : 87 93.
18. Lennox RD, Leahy MJ. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 2004 93 : 142 146.
19. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005 152 : 289 295.
20. Simons FER, Silver NA, Gu X, Simons KJ. Skin concentrations of H1-receptor antagonists. J Allergy Clin Immunol 2001 107 : 526 530.
21. 1-antihistamines. Inflamm Res 2005 54 : 367 369.
22. Spector SL, Shikiar R, Harding G, Meeves S, Leahy MJ. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis 2007 79 : 157 162.
23. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomised, double-blind, placebo-controlled study. Clin Exp Allergy 2004 34 : 1401 1407.
24. Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2006 45 : 469 474.
25. Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. Br J Dermatol 2006 154 : 533 538.